Financiere Saint James
VC Fund
Paris, France
Financiere Saint James is a VC fund in Paris focused on Software and Financial Services. Financiere Saint James is the Family Office of Michaël Benabou, vente-privée.com's co-founder. We invest in digital startups bringing disruptive services to the market. Financiere Saint James invested in companies such Welcome to the Jungle, Glovo, Alma, WeMaintain, Spendesk. Financiere Saint James also invests in PE/VC funds.
- Total investments:
- 103
- Last investment:
- Lead investor:
- 3%
Last updated:
For AI agents: llms.txt
Industries Financiere Saint James invests in
Stages Financiere Saint James invests in
Countries Financiere Saint James invests in
Round sizes
Contacts
| Name | Phone | Socials | |
|---|---|---|---|
Round size
- Seed
- $975k–$6.9M
- Pre-Seed
- $1.6M–$4.3M
- Series A
- $5.2M–$28M
Investment Focus
Industry
- Software 13 (13%)
- Financial Services 9 (9%)
- Artificial Intelligence 9 (9%)
- Internet 8 (8%)
- Information Technology 7 (7%)
Stage
- Seed 34 (33%)
- Series A 25 (24%)
- Pre-Seed 13 (13%)
- Series B 10 (10%)
- Venture - Series Unknown 6 (6%)
Country
- France 59 (57%)
- United States 5 (5%)
- Spain 2 (2%)
- United Kingdom 2 (2%)
- Israel 1 (1%)
Team
| Name | Title | Investments | Links | |
|---|---|---|---|---|
Clément Hardy
Associate
|
Associate | Total investments: 0 | Find email | |
Clément Lamolinerie
Partner
|
Partner | Total investments: 0 | Find email | |
Michael Benabou
President
|
President | Total investments: 29 | Find email | |
Wladimir Mathelin-Moreaux
Associate
|
Associate | Total investments: 0 | Find email |
Investments
| Company | Description | Round | Links |
|---|---|---|---|
| Cleavr is the first AI partner that automatically takes your money. which is linked to your ERP, takes care of everything on its own | $9M / Seed / Oct 06, 2026 | ||
| Onxeo is a biotechnology company that develops drugs for oncology. It offers Beleodaq, a histone deactylase inhibitor for the treatment of peripheral T-cell lymphoma; Livatag, a nanoparticle formulation of doxorubicin, which is in Phase III clinical trials for the treatment of primary liver cancer; Validive, a mucoadhesive buccal tablet that is inPhase II clinical trials for the prevention and the treatment of chemoradioation therapy-induced severe oral mucositis in patients with head and neck cancer; and Combo BelCHOP, which is Phase II clinical trials for the treatment of peripheral T-cell lymphoma.Onxeo is headquartered in Paris, France. | $47M / Post-IPO Equity / Aug 24, 2026 | ||
| CardNexus provides a digital platform for managing, trading, and selling trading card collections. | $4.1M / Pre-Seed / Jun 11, 2026 | ||
| Cleo Labs develops regulatory intelligence and product compliance software that enables companies to manage complex legal requirements across multiple international markets. The company provides an AI-powered platform that identifies applicable regulations for products, mapping obligations related to safety standards, labeling, certifications, andimport requirements across jurisdictions. Its system automates pre-launch compliance workflows by generating regulatory checklists for each product and target market, allowing teams to understand requirements before entering new regions. It also offers continuous monitoring capabilities that track regulatory updates in real time and alert users when changes affect their products or operations. The platform integrates data from thousands of regulatory sources and authorities, applying AI models to analyze legal texts and assess compliance risks for specific product and market combinations. It includes features such as risk scoring, jurisdiction mapping, and automated due diligence checks for supply chains, enabling structured evaluation of compliance exposure. | $1.8M / Pre-Seed / Apr 29, 2026 | ||
| We are a team of French engineers on a mission to change the way we buy Tech Because devices don't have to be new to feel like new! | $17M / Series B / Nov 25, 2025 | ||
| Tomorro is an AI-driven contract lifecycle management platform that automates the processes of contract creation, negotiation, and approval. The platform streamlines workflows for sales teams by providing tools that enhance efficiency and accuracy in contract management. It offers features such as automated document generation, real-timecollaboration, and built-in compliance checks. Tomorro also includes an e-signature solution that facilitates the signing of contracts, ensuring a seamless experience for users. By integrating these functionalities, Tomorro aims to simplify the complexities of contract management for organizations. | $27M / Series B / Mar 31, 2025 | ||
| We transform B2B negotiations with our advanced intelligence platform, empowering finance teams and buyers to lead confidently. Centralize your suppliers, leverage real-time market data to benchmark your terms, and gain a strategic edge in every deal. Secure optimal buying conditions while building and maintaining trusted supplier relationships. | $3.1M / Seed / Nov 21, 2024 | ||
| Linkup connects large language models (LLMs) and AI agents to the internet. The platform enables AI systems to access, search, and interact with web content efficiently, enhancing their capabilities and reducing inaccuracies. By providing APIs, Linkup allows developers to integrate web content into AI applications seamlessly. | $3.2M / Pre-Seed / Nov 18, 2024 | ||
| We transform B2B negotiations with our advanced intelligence platform, empowering finance teams and buyers to lead confidently. Centralize your suppliers, leverage real-time market data to benchmark your terms, and gain a strategic edge in every deal. Secure optimal buying conditions while building and maintaining trusted supplier relationships. | $3.4M / Pre-Seed / Nov 16, 2024 | ||
autone
|
Autone is a SaaS operational platform enabling retail & CPG businesses to make optimal decisions easily and quickly | $16.9M / Series A / Oct 16, 2024 | |
| See all 103 investments → | |||
Co-Investors
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar industry
Similar stage
Similar country
Featured in Investor Lists
Recommended lists
FAQ
What does Financiere Saint James invest in?
Financiere Saint James invests primarily in Software, Financial Services and Artificial Intelligence startups, most often at Seed and Series A stage. Most of the 103 investments tracked by Shizune back companies in France. The Investment Focus section breaks down every industry, stage and country in the portfolio.
What round sizes does Financiere Saint James invest in?
Financiere Saint James typically joins rounds of $975k–$6.9M at Seed, $1.6M–$4.3M at Pre-Seed and $5.2M–$28M at Series A. These are whole funding-round sizes, not Financiere Saint James's own check, which is rarely disclosed: the 10th–90th percentile of the confirmed public funding rounds Financiere Saint James took part in.
How do I contact Financiere Saint James?
Public channels for Financiere Saint James include LinkedIn and the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
Who are the partners at Financiere Saint James?
The team at Financiere Saint James includes Clément Hardy (Associate), Clément Lamolinerie (Partner) and Michael Benabou (President). The Team section lists each member with their title, investment count and links.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Oct 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
